Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,051,624
+$10,023,514 QoQ
Shares Held
39,578
+34315.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,109
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFG Advisory, LLC holds $39,371,083 across 16 Drug Manufacturers - General names. JNJ ranks #2 (25.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
42,985 | $10,816,745 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
39,578 | $10,051,624 | |
| 3 | LLY |
ELI LILLY & Co
|
4,333 | $5,197,130 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
64,156 | $3,696,668 | |
| 5 | AMGN |
Amgen Inc
|
9,053 | $3,278,272 | |
| 6 | MRK |
Merck & Co., Inc.
|
20,458 | $2,628,853 | |
| 7 | PFE |
Pfizer Inc
|
39,164 | $943,069 | |
| 8 | GSK |
GSK plc
|
16,758 | $878,454 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,051,624 | 39,578 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $28,110 | 115 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,541,033 | 41,271 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $7,213,208 | 38,902 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,840,440 | 25,142 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $4,212,004 | 25,398 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,477,919 | 17,134 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,711,749 | 16,733 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $2,391,469 | 16,362 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,562,203 | 16,197 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,457,996 | 15,682 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,532,183 | 16,258 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,746,804 | 16,595 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,542,775 | 16,405 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,782,060 | 15,749 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $3,183,396 | 19,487 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $2,822,053 | 15,898 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,993,878 | 22,535 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $3,026,741 | 17,693 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,862,426 | 17,724 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,949,669 | 17,905 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $3,174,091 | 19,313 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,776,183 | 17,640 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,415,131 | 16,222 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $2,273,987 | 16,170 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,111,061 | 16,099 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||